• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于一名镰状细胞病患者,在红细胞置换输血治疗无效后,成功进行治疗性血浆置换治疗脂肪栓塞综合征。

Successful therapeutic plasma exchange for a patient with sickle cell disease and fat embolism syndrome after a failure of a response to red cell exchange transfusion.

作者信息

Alsaghir Abdullah, Alsaghir Lina, Alsaif Janat, Mobeireek Abdullah

机构信息

Pulmonary & Critical Care Medicine, Dammam Medical Complex, Dammam, Saudi Arabia.

Royal College of Surgeons in Ireland- Bahrain, Busaiteen, Bahrain.

出版信息

Transfusion. 2023 Feb;63 Suppl 1:S33-S36. doi: 10.1111/trf.17220.

DOI:10.1111/trf.17220
PMID:36748667
Abstract

BACKGROUND

Fat embolism syndrome (FES) is a rare complication, which was reported mostly with milder forms of heterozygous sickle cell disease (SCD). It may present in a catastrophic way with multi-organ failure, particularly involving the pulmonary and neurological systems. Diagnosis is often missed or delayed; and the standard recommended treatment is red cell exchange (RCE) transfusion, which has sub-optimal results, such as debilitating long-term neurological complications. Recently, few reports suggested that the addition of Therapeutic Plasma Exchange (TPE) might further improve the outcome.

CASE DESCRIPTION

A 23-year-old woman with homozygote SCD was admitted with bony pains and vaso-occlusive crises. However, her course evolved to respiratory failure requiring mechanical ventilation, decreased level of consciousness, skin rash, severe anemia and thrombocytopenia and a picture consistent with thrombotic microangiopathy. MRI of the brain showed scattered multi-focal ischemic foci and cytotoxic edema. The patient received RCE on the third day after admission without improvement. On the seventh day, TPE was instituted (2 L/day of fresh frozen plasma for 5 days), following which she regained her consciousness and showed an improvement in her laboratory abnormalities. On follow up, she had gradual full neurological recovery and resolution of the MRI findings within a few months.

CONCLUSION

FES remains a diagnostic and therapeutic challenge, with significant morbidity and mortality. Success in the management of this reported case with the addition of TPE to RCE supports the notion that TPE may be a potentially helpful modality that deserves further research.

摘要

背景

脂肪栓塞综合征(FES)是一种罕见的并发症,大多在症状较轻的杂合子镰状细胞病(SCD)中报道。它可能以灾难性的方式出现,伴有多器官功能衰竭,尤其累及肺和神经系统。诊断常常被漏诊或延误;标准推荐治疗是红细胞置换(RCE)输血,但效果欠佳,例如会出现使人衰弱的长期神经并发症。最近,有少数报告表明,加用治疗性血浆置换(TPE)可能会进一步改善治疗结果。

病例描述

一名23岁的纯合子SCD女性因骨痛和血管闭塞性危象入院。然而,她的病情发展为呼吸衰竭,需要机械通气,意识水平下降,出现皮疹、严重贫血和血小板减少,以及与血栓性微血管病相符的症状。脑部MRI显示散在的多灶性缺血灶和细胞毒性水肿。患者在入院后第三天接受RCE治疗,但病情无改善。在第七天,开始进行TPE治疗(每天2升新鲜冰冻血浆,共5天),之后她恢复了意识,实验室异常情况也有所改善。随访时,她在几个月内逐渐完全恢复神经功能,MRI检查结果也消失。

结论

FES仍然是一个诊断和治疗难题,具有较高的发病率和死亡率。在本报告病例中,RCE加用TPE治疗取得成功,支持了TPE可能是一种潜在有用的治疗方式,值得进一步研究的观点。

相似文献

1
Successful therapeutic plasma exchange for a patient with sickle cell disease and fat embolism syndrome after a failure of a response to red cell exchange transfusion.对于一名镰状细胞病患者,在红细胞置换输血治疗无效后,成功进行治疗性血浆置换治疗脂肪栓塞综合征。
Transfusion. 2023 Feb;63 Suppl 1:S33-S36. doi: 10.1111/trf.17220.
2
Further evidence for the benefit of therapeutic plasma exchange for acute multi-organ failure syndrome refractory to red cell exchange in sickle cell disease.对于镰状细胞病中对红细胞置换难治的急性多器官功能衰竭综合征,治疗性血浆置换有益的进一步证据。
J Clin Apher. 2021 Oct;36(5):777-779. doi: 10.1002/jca.21920. Epub 2021 Jun 30.
3
Complete neurological recovery from fat embolism syndrome in sickle cell disease after sequential red cell exchange transfusion and therapeutic plasma exchange.序贯红细胞置换术和治疗性血浆置换术治疗镰状细胞病脂肪栓塞综合征后完全神经功能恢复。
Transfus Apher Sci. 2021 Dec;60(6):103226. doi: 10.1016/j.transci.2021.103226. Epub 2021 Jul 29.
4
Case series supporting heme detoxification via therapeutic plasma exchange in acute multiorgan failure syndrome resistant to red blood cell exchange in sickle cell disease.病例系列支持镰状细胞病中对红细胞置换耐药的急性多器官功能衰竭综合征通过治疗性血浆置换进行血红素解毒。
Transfusion. 2018 Feb;58(2):470-479. doi: 10.1111/trf.14407. Epub 2017 Nov 27.
5
A Case of Fat Embolism Syndrome with Cerebral Involvement in Sickle Cell Anemia.镰状细胞贫血伴脑受累的脂肪栓塞综合征一例。
Hemoglobin. 2021 Jul;45(4):269-273. doi: 10.1080/03630269.2021.1990081. Epub 2021 Nov 8.
6
Thrombotic microangiopathy in sickle cell disease crisis.镰状细胞病危象中的血栓性微血管病。
Ann Hematol. 2013 Apr;92(4):509-15. doi: 10.1007/s00277-012-1647-3. Epub 2012 Dec 7.
7
Coma secondary to cerebral fat embolism syndrome due to sickle cell disease fully recovering following red cell exchange transfusion.因镰状细胞病导致的脑脂肪栓塞综合征引起的昏迷,在红细胞交换输血后完全恢复。
BMJ Case Rep. 2021 Nov 12;14(11):e245051. doi: 10.1136/bcr-2021-245051.
8
Fat Embolism Syndrome in Sickle Cell β-Thalassemia Patient With Osteonecrosis: An Uncommon Presentation in a Young Adult.镰状细胞β-地中海贫血伴骨坏死患者的脂肪栓塞综合征:青年患者的一种罕见表现。
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211012266. doi: 10.1177/23247096211012266.
9
Plasma exchange in critically ill patients with sickle cell disease.镰状细胞病危重症患者的血浆置换
Transfus Apher Sci. 2007 Aug;37(1):17-22. doi: 10.1016/j.transci.2006.12.009. Epub 2007 Aug 17.
10
Plasma exchange-A useful adjunct therapy to red cell exchange in patients with sickle cell disease and multiorgan dysfunction.血浆置换——治疗镰状细胞病伴多器官功能障碍患者红细胞置换的有效辅助疗法。
Transfusion. 2023 Jul;63(7):1384-1390. doi: 10.1111/trf.17448. Epub 2023 Jun 15.

引用本文的文献

1
Thrombotic microangiopathic anemia in patients with sickle cell disease and its variants during a vaso-occlusive crisis.镰状细胞病及其变异型患者在血管闭塞性危象期间的血栓性微血管病性贫血
Res Pract Thromb Haemost. 2025 Mar 18;9(2):102734. doi: 10.1016/j.rpth.2025.102734. eCollection 2025 Feb.
2
Logistics, risks, and benefits of automated red blood cell exchange for patients with sickle cell disease.自动化红细胞置换治疗镰状细胞病患者的物流、风险和获益。
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):646-652. doi: 10.1182/hematology.2023000498.